152 related articles for article (PubMed ID: 17881359)
1. p53 is a key molecular target of ursodeoxycholic acid in regulating apoptosis.
Amaral JD; Castro RE; Solá S; Steer CJ; Rodrigues CM
J Biol Chem; 2007 Nov; 282(47):34250-9. PubMed ID: 17881359
[TBL] [Abstract][Full Text] [Related]
2. Ursodeoxycholic acid modulates E2F-1 and p53 expression through a caspase-independent mechanism in transforming growth factor beta1-induced apoptosis of rat hepatocytes.
Sola S; Ma X; Castro RE; Kren BT; Steer CJ; Rodrigues CM
J Biol Chem; 2003 Dec; 278(49):48831-8. PubMed ID: 14514686
[TBL] [Abstract][Full Text] [Related]
3. Modulation of nuclear steroid receptors by ursodeoxycholic acid inhibits TGF-beta1-induced E2F-1/p53-mediated apoptosis of rat hepatocytes.
Solá S; Castro RE; Kren BT; Steer CJ; Rodrigues CM
Biochemistry; 2004 Jul; 43(26):8429-38. PubMed ID: 15222754
[TBL] [Abstract][Full Text] [Related]
4. Ursodeoxycholic acid modulates the ubiquitin-proteasome degradation pathway of p53.
Amaral JD; Castro RE; Solá S; Steer CJ; Rodrigues CM
Biochem Biophys Res Commun; 2010 Oct; 400(4):649-54. PubMed ID: 20807506
[TBL] [Abstract][Full Text] [Related]
5. miR-34a/SIRT1/p53 is suppressed by ursodeoxycholic acid in the rat liver and activated by disease severity in human non-alcoholic fatty liver disease.
Castro RE; Ferreira DM; Afonso MB; Borralho PM; Machado MV; Cortez-Pinto H; Rodrigues CM
J Hepatol; 2013 Jan; 58(1):119-25. PubMed ID: 22902550
[TBL] [Abstract][Full Text] [Related]
6. Differential regulation of cyclin D1 and cell death by bile acids in primary rat hepatocytes.
Castro RE; Amaral JD; Solá S; Kren BT; Steer CJ; Rodrigues CM
Am J Physiol Gastrointest Liver Physiol; 2007 Jul; 293(1):G327-34. PubMed ID: 17431217
[TBL] [Abstract][Full Text] [Related]
7. Multiple cyclin kinase inhibitors promote bile acid-induced apoptosis and autophagy in primary hepatocytes via p53-CD95-dependent signaling.
Zhang G; Park MA; Mitchell C; Walker T; Hamed H; Studer E; Graf M; Rahmani M; Gupta S; Hylemon PB; Fisher PB; Grant S; Dent P
J Biol Chem; 2008 Sep; 283(36):24343-58. PubMed ID: 18614532
[TBL] [Abstract][Full Text] [Related]
8. Modulation of hepatocyte apoptosis: cross-talk between bile acids and nuclear steroid receptors.
Solá S; Amaral JD; Aranha MM; Steer CJ; Rodrigues CM
Curr Med Chem; 2006; 13(25):3039-51. PubMed ID: 17073645
[TBL] [Abstract][Full Text] [Related]
9. Mechanism of apoptotic effects induced selectively by ursodeoxycholic acid on human hepatoma cell lines.
Liu H; Qin CY; Han GQ; Xu HW; Meng M; Yang Z
World J Gastroenterol; 2007 Mar; 13(11):1652-8. PubMed ID: 17461466
[TBL] [Abstract][Full Text] [Related]
10. No evidence of direct binding between ursodeoxycholic acid and the p53 DNA-binding domain.
Amaral JD; Correia AR; Steer CJ; Gomes CM; Rodrigues CM
Biosci Rep; 2010 Jun; 30(5):359-64. PubMed ID: 19811448
[TBL] [Abstract][Full Text] [Related]
11. Nuclear translocation of UDCA by the glucocorticoid receptor is required to reduce TGF-beta1-induced apoptosis in rat hepatocytes.
Solá S; Amaral JD; Castro RE; Ramalho RM; Borralho PM; Kren BT; Tanaka H; Steer CJ; Rodrigues CM
Hepatology; 2005 Oct; 42(4):925-34. PubMed ID: 16175607
[TBL] [Abstract][Full Text] [Related]
12. A novel role for ursodeoxycholic acid in inhibiting apoptosis by modulating mitochondrial membrane perturbation.
Rodrigues CM; Fan G; Ma X; Kren BT; Steer CJ
J Clin Invest; 1998 Jun; 101(12):2790-9. PubMed ID: 9637713
[TBL] [Abstract][Full Text] [Related]
13. [Ursodeoxycholic acid inhibits hepatocyte-like cell apoptosis by down-regulating the expressions of Bax and Caspase-3].
Ji WJ; Qu Q; Jin Y; Zhao L; He XD
Zhonghua Yi Xue Za Zhi; 2009 Nov; 89(42):2997-3001. PubMed ID: 20137712
[TBL] [Abstract][Full Text] [Related]
14. Targeting the p53 pathway of apoptosis.
Amaral JD; Xavier JM; Steer CJ; Rodrigues CM
Curr Pharm Des; 2010; 16(22):2493-503. PubMed ID: 20500145
[TBL] [Abstract][Full Text] [Related]
15. The effect of ursodeoxycholic acid on glycochenodeoxycholic acid-induced apoptosis in rat hepatocytes.
Utanohara S; Tsuji M; Momma S; Morio Y; Oguchi K
Toxicology; 2005 Oct; 214(1-2):77-86. PubMed ID: 16023280
[TBL] [Abstract][Full Text] [Related]
16. Ursodeoxycholic acid prevents cytochrome c release in apoptosis by inhibiting mitochondrial membrane depolarization and channel formation.
Rodrigues CM; Ma X; Linehan-Stieers C; Fan G; Kren BT; Steer CJ
Cell Death Differ; 1999 Sep; 6(9):842-54. PubMed ID: 10510466
[TBL] [Abstract][Full Text] [Related]
17. Changes in expression and immunolocalization of protein associated with toxic bile salts-induced apoptosis in rat hepatocytes.
Oh SH; Yun KJ; Nan JX; Sohn DH; Lee BH
Arch Toxicol; 2003 Feb; 77(2):110-5. PubMed ID: 12590363
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of the MAPK and PI3K pathways enhances UDCA-induced apoptosis in primary rodent hepatocytes.
Qiao L; Yacoub A; Studer E; Gupta S; Pei XY; Grant S; Hylemon PB; Dent P
Hepatology; 2002 Apr; 35(4):779-89. PubMed ID: 11915023
[TBL] [Abstract][Full Text] [Related]
19. A distinct microarray gene expression profile in primary rat hepatocytes incubated with ursodeoxycholic acid.
Castro RE; Solá S; Ma X; Ramalho RM; Kren BT; Steer CJ; Rodrigues CM
J Hepatol; 2005 Jun; 42(6):897-906. PubMed ID: 15885361
[TBL] [Abstract][Full Text] [Related]
20. Ursodeoxycholic acid may inhibit deoxycholic acid-induced apoptosis by modulating mitochondrial transmembrane potential and reactive oxygen species production.
Rodrigues CM; Fan G; Wong PY; Kren BT; Steer CJ
Mol Med; 1998 Mar; 4(3):165-78. PubMed ID: 9562975
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
